A banner displays a Teva Pharmaceutical Industries Ltd. logo at the entrance to the company’s new factory in Godollo, Hungary.
Akos Stiller | Bloomberg | Getty Images
Teva Pharmaceutical shares surged Monday after announcing a settlement that would resolve all of its allegations that it helped fuel the nation’s opioid crisis.
The stock rose as much as 13% in intraday trading.
“The company is pleased to positively contribute to solving the nationwide opioid epidemic,” the company in a statement. “Teva has consistently committed to complying with all laws and regulations regarding its manufacture and sale of opioids. Neither settlement includes an admission of liability.”
This is a developing story. Please check back for updates.
Visit source link
This website is created with original content & Premium content sources. All rights reserved and belongs to respective authors.